Kojima Shu-Ichi, Kojima Ken, Fujita Tomoe
Department of Pharmacology and Toxicology, Dokkyo Medical University School of Medicine, Mibu, Tochigi 321-0293, Japan.
Department of Pharmacology and Toxicology, Dokkyo Medical University School of Medicine, Mibu, Tochigi 321-0293, Japan.
Eur J Pharmacol. 2017 Mar 15;799:196-200. doi: 10.1016/j.ejphar.2017.02.011. Epub 2017 Feb 9.
The effect of a 5-HT receptor-selective agonist SR57227A was investigated on the outflow of 5-hydroxytryptamine (5-HT) from isolated muscle layer-free mucosal preparations of guinea-pig colon. The mucosal preparations were incubated in vitro and the outflow of 5-HT from these preparations was determined by high-performance liquid chromatography with electrochemical detection. SR57227A (100μM) produced a tetrodotoxin-resistant and sustained increase in the outflow of 5-HT from the mucosal preparations. The SR57227A-evoked sustained 5-HT outflow was completely inhibited by the 5-HT receptor antagonist ramosetron (1μM). The neuropeptide Y receptor antagonist BIBO3304 (100nM) partially inhibited the SR57227A-evoked sustained 5-HT outflow, but the Y receptor antagonist BIIE0246 (1μM) or the glucagon-like peptide-1 (GLP-1) receptor antagonist exendin-(9-39) (1μM), showed a minimal effect on the SR57227A-evoked sustained 5-HT outflow. In the presence of BIBO3304 (100nM) and exendin-(9-39) (1μM), SR57227A (100μM) failed to produce a sustained increase in the outflow of 5-HT. The Y receptor agonist [Leu, Pro]-neuropeptide Y (10nM), but not GLP-1-(7-36) amide (100nM), produced a sustained increase in the outflow of 5-HT. We found that 5-HT receptor-triggered 5-HT release from guinea-pig colonic mucosa is mediated by the activation of 5-HT receptors located at endocrine cells (enterochromaffin cells and peptide YY (PYY)-containing endocrine cells). The activation of both Y and GLP-1 receptors appears to be required for the maintenance of 5-HT receptor-triggered 5-HT release. It is therefore considered that 5-HT receptors located at colonic mucosa play a crucial role in paracrine signaling between enterochromaffin cells and PYY-containing endocrine cells.
研究了5-羟色胺(5-HT)受体选择性激动剂SR57227A对豚鼠结肠无肌层黏膜分离制剂中5-羟色胺(5-HT)流出的影响。将黏膜制剂进行体外孵育,并通过高效液相色谱-电化学检测法测定这些制剂中5-HT的流出量。SR57227A(100μM)使黏膜制剂中5-HT的流出产生了对河豚毒素不敏感的持续增加。5-HT受体拮抗剂雷莫司琼(1μM)完全抑制了SR57227A诱发的5-HT持续流出。神经肽Y受体拮抗剂BIBO3304(100nM)部分抑制了SR57227A诱发的5-HT持续流出,但Y受体拮抗剂BIIE0246(1μM)或胰高血糖素样肽-1(GLP-1)受体拮抗剂艾塞那肽(9-39)(1μM)对SR57227A诱发的5-HT持续流出影响极小。在存在BIBO3304(100nM)和艾塞那肽(9-39)(1μM)的情况下,SR57227A(100μM)未能使5-HT流出产生持续增加。Y受体激动剂[亮氨酸,脯氨酸]-神经肽Y(10nM)而非GLP-1-(7-36)酰胺(100nM)使5-HT流出产生了持续增加。我们发现,5-HT受体触发的豚鼠结肠黏膜5-HT释放是由位于内分泌细胞(肠嗜铬细胞和含肽YY(PYY)的内分泌细胞)的5-HT受体激活介导的。Y和GLP-1受体的激活似乎都是维持5-HT受体触发的5-HT释放所必需的。因此认为,位于结肠黏膜的5-HT受体在肠嗜铬细胞和含PYY的内分泌细胞之间的旁分泌信号传导中起关键作用。